Is it possible to give Inotuzumab ozogamicin in the front line setting for an older patient with Ph- Pre-B-ALL?
Answer from: at Academic Institution
Yes - there are encouraging data from early-phase trials looking at InO-containing regimens in the frontline setting. Some of these include:
Alliance A041703 (InO followed by blinatumomab for older adults with CD22+, CD19+, Ph-negative B-ALL): Wieduwilt et al., Journal of Clinical Oncology 2023, su...
Comments
Medical Oncologist at Riverside Methodist Hospitals/OhioHealth Thanks! I am aware of such! My question is: can we...
Thanks! I am aware of such! My question is: can we...